Abstract
The cornea provides two thirds of the refractive power of the eye and protection against insults such as infection and injury. The outermost tissue of the cornea is renewed by stem cells located in the limbus. Depletion or destruction of these stem cells may lead to blinding limbal stem cell deficiency (LSCD) that concerns millions of patients around the world. Innovative strategies based on adult stem cell therapies have been developed in the recent years but they are still facing numerous unresolved issues, and the long term results can be deceiving. Today there is a clear need to improve these therapies, and/or to develop new approaches for the treatment of LSCD. Here, we review the current cell-based therapies used for the treatment of ocular diseases, and discuss the potential of pluripotent stem cells (embryonic and induced pluripotent stem cells) in corneal repair. As the secretion of paracrine factors is known to have a crucial role in maintaining stem cell homeostasis and in wound repair, we also consider the therapeutic potential of a promising novel pathway, the exosomes. Exosomes are nano-sized vesicles that have the ability to transfer RNAs and proteins to recipient cells, and several studies demonstrated their role in cell protection and wound healing. Exosomes could circumvent the hurdles of stem-cell based approaches, and they could become a strong candidate as an alternative therapy for ocular surface diseases.
Similar content being viewed by others
References
Echevarria, T. J., & Di Girolamo, N. (2011). Tissue-regenerating, vision-restoring corneal epithelial stem cells. Stem Cell Reviews and Reports, 7(2), 256–268.
Ahmad, S. (2012). Concise review- LSCD, dysfunction and distress. Stem Cells Translational Medicine, 1(2), 110–115.
Pellegrini, G., Rama, P., Di Rocco, A., Panaras, A., & De Lucas, M. (2014). Concise review: hurdles in a successful example of limbal stem cell based regenerative medicine. Stem Cells, 32(1), 26–34.
He, H., & Yiu, S. C. (2014). Stem cell-based therapy for treating limbal stem cells deficiency: a review of different strategies. Saudi Journal Ophthalmology, 28(3), 188–194.
Vemuganti, G. K., Fatima, A., Madhira, S. L., Basti, S., & Sangwan, V. S. (2009). Limbal stem cells: application in ocular biomedicine. International Review of Cell and Molecular Biology, 275, 133–181.
Espana, E. M., Di Pascuale, M., Grueterich, M., Solomon, A., & Tseng, S. C. G. (2004). Keratolimbal allograft in corneal reconstruction. Eye (London), 18(4), 406–417.
Sejpal, K., Bakhtiari, P., & Deng, S. X. (2013). Presentation, diagnosis and management of limbal stem cell deficiency. Middle East African Journal of Ophthalmology, 20(1), 5–10.
Anderson, D. F. (2001). Amniotic membrane transplantation for partial limbal stem cell deficiency. British Journal of Ophthalmology, 85(5), 567–575.
Pellegrini, G., Traverso, C. E., Franzi, A. T., Zingirian, M., Cancceda, R., & De Lucas, M. (1997). Long-term restoration of damaged corneal surfaces with autologous cultivated corneal epithelium. Lancet, 349(9057), 990–993.
Sangwan, V. S., Matalia, H. P., Vermuganti, G. K., Fatima, A., Ifthekar, G., Singh, S., et al. (2006). Clinical outcome of autologous cultivated limbal epithelium transplantation. Indian Journal of Ophthalmology, 54(1), 29–34.
Rama, P., Matuska, S., Paganoni, G., Spinelli, A., De Lucas, M., & Pelligrini, G. (2010). Limbal stem-cell therapy and long-term corneal regeneration. New England Journal of Medicine, 363(2), 147–155.
Shortt, A. J., Secker, G. A., Notara, M. D., Limb, G. A., Khaw, P. T., Tuft, S. J., et al. (2007). Transplantation of ex vivo cultured limbal epithelial stem cells: a review of techniques and clinical results. Survey of Ophthalmology, 52(5), 483–502.
Di Girolamo, N., Bosch, M., Zamora, K., Coroneo, M. T., Wakefield, D., & Watson, S. L. (2009). A contact lens-based technique for expansion and transplantation of autologous epithelial progenitors for ocular surface reconstruction. Transplantation, 87(10), 1571–1578.
Baylis, O., Figueiredo, F., Henein, C., Lako, M., & Ahmad, S. (2011). 13 Years of cultured limbal epithelial cell therapy: a review of the outcomes. Journal of Cellular Biochemistry, 112(4), 993–1002.
Hayashida, Y., Nishida, K., Yamato, M., Watanabe, K., Maeda, N., Watanabe, H., et al. (2005). Ocular surface reconstruction using autologous rabbit oral mucosal epithelial sheets fabricated ex vivo on a temperature-responsive culture surface. Investigative Ophthalmology and Visual Science, 46(5), 1632–1639.
Inatomi, T., Nakamura, T., Koizumi, N., Sotozono, C., Yokoi, N., & Kinoskita, S. (2006). Midterm results on ocular surface reconstruction using cultivated autologous oral mucosal epithelial transplantation. American Journal of Ophthalmology, 141(2), 267–275.
Kolli, S., Ahmad, S., Mudhar, H. S., Meeny, A., Lako, M., & Fequeiredo, F. C. (2014). Successful application of ex vivo expanded human autologous oral mucosal epithelium for the treatment of total bilateral limbal stem cell deficiency. Stem Cells, 32(8), 2135–2146.
Priya, C. G., Arpitha, P., Vaishali, S., Prajna, N. V., Usha, K., Sheetal, K., et al. (2011). Adult human buccal epithelial stem cells: identification, ex-vivo expansion, and transplantation for corneal surface reconstruction. Eye (London), 25(12), 1641–1649.
Burillon, C., Huot, L., Justin, V., Nataf, S., Chapuis, F., Decullier, E., et al. (2012). Cultured autologous oral mucosal epithelial cell sheet (CAOMECS) transplantation for the treatment of corneal limbal epithelial stem cell deficiency. Investigative Ophthalmology and Visual Science, 53(3), 1325–1331.
Sotozono, C., Inatomi, T., Nakamura, T., Koizumi, N., Yokoi, N., Ueta, M., et al. (2014). Cultivated oral mucosal epithelial transplantation for persistent epithelial defect in severe ocular surface diseases with acute inflammatory activity. Acta Ophthalmologica, 92(6), e447–e453.
Utheim, T. P. (2015). Concise review: transplantation of cultured oral mucosal epithelial cells for treating limbal stem cell deficiency-current status and future perspectives. Stem Cells, 33, 1685–1695.
Chun, Y. S., Park, I. K., & Kim, J. C. (2011). Technique for autologous nasal mucosa transplantation in severe ocular surface disease. European Journal of Ophtalmology, 21(5), 545–551.
Konno, M., Hamabe, A., Hasegawa, S., Ogawa, H., Fukusumi, T., Nishikawa, et al. (2013). Adipose-derived mesenchymal stem cells and regenerative medicine. Development Growth and Differentiation, 55(3), 309–318.
Ma, Y., Xu, Y., Xiao, Z., Yang, W., Zhang, C., Song, E., et al. (2006). Reconstruction of chemically burned rat corneal surface by bone marrow-derived human mesenchymal stem cells. Stem Cells, 24(2), 315–321.
Gu, S., Xing, C., Han, J., Tso, M. O. M., & Hong, J. (2009). Differentiation of rabbit bone marrow mesenchymal stem cells into corneal epithelial cells in vivo and ex vivo. Molecular Vision, 15, 99–107.
Jiang, T.-S., Cai, L., Ji, W. Y., Hui, Y. N., Wang, Y. S., Hu, D., et al. (2010). Reconstruction of the corneal epithelium with induced marrow mesenchymal stem cells in rats. Molecular Vision, 16, 1304–1316.
Nieto-Miguel, T., Galindo, S., Reinoso, R., Corell, A., Martino, M., Perez-Simon, J. A., et al. (2013). et al. In vitro simulation of corneal epithelium microenvironment induces a corneal epithelial-like cell phenotype from human adipose tissue mesenchymal stem cells. Current Eye Research, 38(9), 933–944.
Advanced Therapy for Ocular Surface Reconstruction. Allogenic Limbus Epithelial Stem-cell Transplant vs Bone Marrow Mesenchymal Stem-cell Transplant in Limbus Insufficiency Syndrome. Double-masked Randomized Trial. ClinicalTrials.gov identifier: NCT015620. Available at clinicaltrials.gov
The Subconjunctival Injection of Human Bone Marrow Mesenchymal Stem Cells for Ocular Corneal Burn: Prospective, Double-blind, Randomized, Controlled Trial. ClinicalTrials.gov identifier: NCT02325843. Available at clinicaltrials.gov
Monteiro, B. G., Serafim, R. C., Melo, G. B., Silva, M. C., Lizier, N. F., Maranduba, C. M., et al. (2009). Human immature dental pulp stem cells share key characteristic features with limbal stem cells. Cell Proliferation, 42(5), 587–594.
Reza, H. M., Ng, B.-Y., Gimeno, F. L., Phan, T. T., & Ang, L. P.-K. (2011). Umbilical cord lining stem cells as a novel and promising source for ocular surface regeneration. Stem Cell Reviews, 7(4), 935–947.
Meyer-Blazejewska, E. A., Call, M. K., Yamanaka, O., Liu, H., Schlotzer-Schrehardt, U., et al. (2011). From hair to cornea: toward the therapeutic use of hair follicle-derived stem cells in the treatment of limbal stem cell deficiency. Stem Cells, 29(1), 57–66.
Wernig, M., Meissner, A., Foreman, R., Brambrink, T., Ku, M., & Hochedlinger, K. (2007). In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature, 448(7151), 318–324.
Okita, K., Ichisaka, T., & Yamanaka, S. (2007). Generation of germline-competent induced pluripotent stem cells. Nature, 448(7151), 313–317.
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., et al. (1998). Embryonic stem cell lines derived from human blastocysts. Science, 282(5391), 1145–1147.
De Lázaro, I., Yilmazer, A., & Kostarelos, K. (2014). Induced pluripotent stem (iPS) cells: a new source for cell-based therapeutics? Journal of Controlled Release, 185, 37–44.
Cloutier, F., Siegenthaler, M. M., Nistor, G., & Keirstead, H. S. (2006). Transplantation of human embryonic stem cell-derived oligodendrocyte progenitors into rat spinal cord injuries does not cause harm. Regenerative Medicine, 1(14), 469–479.
Pêgo, A. P., Kubinova, S., Cizkova, D., Vanicky, I., Mar, F. M., Sousa, M. M., et al. (2012). Regenerative medicine for the treatment of spinal cord injury: more than just promises? Journal of Cellular and Molecular Medicine, 16(11), 2564–2582.
Hanna, J., Wernig, M., Markoulaki, S., Sun, C. W., Meissner, A., Cassady, J. P., et al. (2007). Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science, 318(5858), 1920–1923.
Li, Z., Wu, J. C., Sheikh, A. Y., Kraft, D., Cao, F., Xie, X., et al. (2007). Differentiation, survival, and function of embryonic stem cell derived endothelial cells for ischemic heart disease. Circulation, 116(11 Suppl), I46–I54.
Laflamme, M. A., Chen, K. Y., Naumova, A. V., Muskheli, V., Fugate, J. A., Dupras, S. K., et al. (2007). Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nature Biotechnology, 25(9), 1015–1024.
Chong, J. J., Yang, X., Don, C. W., Minami, E., Liu, Y. W., Weyers, J. J., et al. (2014). Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature, 510(7504), 273–277.
Kawamura, M., Miyagawa, S., Fukushima, S., Saito, A., Miki, K., Ito, E., et al. (2013). Enhanced survival of transplanted human induced pluripotent stem cell-derived cardiomyocytes by the combination of cell sheets with the pedicled omental flap technique in a porcine heart. Circulation, 128(11 Suppl1), S87–S94.
Christoforou, N., Oskouei, B. N., Esteso, P., Hill, C. M., Zimmet, J. M., Bian, W., et al. (2010). Implantation of mouse embryonic stem cell-derived cardiac progenitor cells preserves function of infarcted murine hearts. PloS One, 5(7), e11536.
Xiong, Q., Ye, L., Zhang, P., Lepley, M., Tian, J., Li, J., et al. (2013). Functional consequences of human induced pluripotent stem cell therapy: myocardial ATP turnover rate in the in vivo swine heart with postinfarction remodeling. Circulation, 127(9), 997–1008.
Darabi, R., Arpke, R. W., Irion, S., Dimos, J. T., Grskovic, M., Kyba, M., et al. (2012). Human ES- and iPS-derived myogenic progenitors restore DYSTROPHIN and improve contractility upon transplantation in dystrophic mice. Cell Stem Cell, 10(5), 610–619.
Gonzalez-Cordero, A., West, E. L., Pearson, R. A., Duran, Y., Carvalho, L. S., Chu, C. J., et al. (2013). Photoreceptor precursors derived from three-dimensional embryonic stem cell cultures integrate and mature within adult degenerate retina. Nature Biotechnology, 31(8), 741–747.
Soria, B., Roche, E., Berna, G., Leon-Quinto, T., Reig, J. A., & Martin, F. (2000). Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes, 49(2), 157–162.
Antonica, F., Kasprzyk, D. F., Opitz, R., Iacovino, M., Liao, X. H., & Dumitrescu, A. M. (2012). Generation of functional thyroid from embryonic stem cells. Nature, 491(7422), 66–71.
Schwartz, S. D., Regillo, C. D., Lam, B. L., Eliott, D., Rosenfeld, P. J., Gregori, N. Z., et al. (2014). Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt’s macular dystrophy: follow-up of two open-label phase 1/2 studies. Lancet, 385(9967), 509–516.
Menasché, P., Vanneaux, V., Hagège, A., Bel, A., Cholley, B., Cacciapuoti, I., et al. (2015). Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report. European Heart Journal, 36(30), 2011–2017.
Alonso-Alonso, M. L., & Srivastava, G. K. (2015). Current focus of stem cell application in retinal repair. World Journal of Stem Cells, 7(30), 641–648.
Kamao, H., Mandai, M., Okamoto, S., Sakai, N., Suga, A., Sugita, S., et al. (2014). Characterization of human induced pluripotent stem cell-derived retinal pigment epithelium cell sheets aiming for clinical application. Stem Cell Reports, 2(2), 205–218.
Nakano-Okuno, M., Borah, B. R., & Nakano, I. (2014). Ethics of iPSC-based clinical research for age-related macular degeneration: patient-centered risk-benefit analysis. Stem Cell Reviews, 10(6), 743–752.
RIKEN and Foundation for Biomedical Research and Innovation (2015) Report available at http://www.riken-ibri.jp/AMD/img/20150319.pdf in Japanese
Aberdam, E., Barak, E., Rouleau, M., de LaForest, S., Berrih-Aknin, S., Suter, D. M., et al. (2008). A pure population of ectodermal cells derived from human embryonic stem cells. Stem Cells, 26(2), 440–444.
Wolosin, J. M., Budak, M. T., & Akinci, M. A. (2004). Ocular surface epithelial and stem cell development. International Journal of Developmental Biology, 48(8–9), 981–991.
Homma, R., Yoshikawa, H., Takeno, M., Kurokawa, M. S., Masuda, C., Takada, E., et al. (2004). Induction of epithelial progenitors in vitro from mouse embryonic stem cells and application for reconstruction of damaged cornea in mice. Investigative Ophthalmology and Visual Science, 45(12), 4320–4326.
Ahmad, S., Stewart, R., Yung, S., Kolli, S., Armstrong, L., Stojkovic, M., et al. (2007). Differentiation of human embryonic stem cells into corneal epithelial-like cells by in vitro replication of the corneal epithelial stem cell niche. Stem Cells, 25(5), 1145–1155.
Notara, M., Hernandez, D., Mason, C., & Daniels, J. T. (2012). Characterization of the phenotype and functionality of corneal epithelial cells derived from mouse embryonic stem cells. Regenerative Medicine, 7(2), 167–178.
Shalom-Feuerstein, R., Serror, L., De La Forest Divonne, S., Petit, I., Aberdam, E., Camargo, L., et al. (2012). Pluripotent stem cell model reveals essential roles for miR-450b-5p and miR-184 in embryonic corneal lineage specification. Stem Cells, 30(5), 898–909.
Petit, I., Kesner, N. S., Karry, R., Robicsek, O., Aberdam, E., Müller, F. J., et al. (2012). Induced pluripotent stem cells from hair follicles as a cellular model for neurodevelopmental disorders. Stem Cell Research, 8(1), 134–140.
Aberdam, D., Gambaro, K., Rostagno, P., Aberdam, E., De La Forest Divonne, S., & Rouleau, M. (2007). Key role of p63 in BMP-4-induced epidermal commitment of embryonic stem cells. Cell Cycle, 6(3), 291–294.
Hayashi, R., Ishikawa, Y., Kageyama, T., Takashiba, K., Fujioka, T., Tsujikawa, M., et al. (2012). Generation of corneal epithelial cells from induced pluripotent stem cells derived from human dermal fibroblast and corneal limbal epithelium. PloS One, 7(9), 1–10.
Sareen, D., Saghizadeh, M., Ornelas, L., Winkler, M. A., Narwani, K., Sahabian, A., et al. (2014). Differentiation of human limbal-derived induced pluripotent stem cells into limbal-like epithelium. Stem Cells Translational Medicine, 3(9), 1002–1012.
Mikhailova, A., Ilmarinen, T., Uusitalo, H., & Skottman, H. (2014). Small-molecule induction promotes corneal epithelial cell differentiation from human induced pluripotent stem cells. Stem Cell Reports, 2(2), 219–223.
Chan, A. A., Hertsenberg, A. J., Funderburgh, M. L., Mann, M. M., Du, Y., Davoli, K. A., et al. (2013). Differentiation of human embryonic stem cells into cells with corneal keratocyte phenotype. PloS One, 8(2), 1–9.
Taylor, C. J., Peacock, S., Chaudhry, A. N., Bradley, J. A., & Bolton, E. M. (2012). Generating an iPSC bank for HLA-matched tissue transplantation based on known donor and recipient HLA types. Cell Stem Cell, 11(2), 147–152.
Zhu, J., Zhang, K., Sun, Y., Gao, X., Li, Y., Chen, Z., et al. (2013). Reconstruction of functional ocular surface by acellular porcine cornea matrix scaffold and limbal stem cells derived from human embryonic stem cells. Tissue Engineering Part A, 19(21–22), 2412–2425.
Assawachananont, J., Mandai, M., Okamoto, S., Yamada, C., Eiraku, M., Yonemura, S., et al. (2014). Transplantation of embryonic and induced pluripotent stem cell-derived 3D retinal sheets into retinal degenerative mice. Stem Cell Reports, 2(5), 662–674.
Sterneckert, J. L., Reinhardt, P., & Schöler, H. R. (2014). Investigating human disease using stem cell models. Nature Reviews Genetics, 15(9), 625–639.
Lancaster, M. A., & Knoblich, J. A. (2014). Organogenesis in a dish: modeling development and disease using organoid technologies. Science, 345(6194), 1247125.
Giri, S., & Bader, A. (2015). A low-cost, high-quality new drug discovery process using patient-derived induced pluripotent stem cells. Drug Discovery Today, 20(1), 37–49.
Wang, J., et al. (2015). Generation of clinical-grade human induced pluripotent stem cells in Xeno-free conditions. Stem Cell Research & Therapy, 6, 223.
Watt, F. M., & Hogan, B. L. (2000). Out of Eden: stem cells and their niches. Science, 287(5457), 1427–1430.
Gnecchi, M., Zhang, Z., Ni, A., & Dzau, V. J. (2008). Paracrine mechanisms in adult stem cell signaling and therapy. Circulation Research, 103(11), 1204–1219.
Liu, Z., Wan, P., Duan, H., Zhou, J., Tan, B., Liu, Y., et al. (2013). ES micro-environment enhances stemness and inhibits apoptosis in human limbal stem cells via the maintenance of telomerase activity. PloS One, 8(1), 1–14.
Chien, Y., Liao, Y. W., Liu, D. M., Lin, H. L., Chen, S. J., Chen, H. L., et al. (2012). Corneal repair by human corneal keratocyte-reprogrammed iPSCs and amphiphatic carboxymethyl-hexanoyl chitosan hydrogel. Biomaterials, 33(32), 8003–8016.
Yu, D., Chen, M., Sun, X., & Ge, J. (2013). Differentiation of mouse induced pluripotent stem cells into corneal epithelial-like cells. Cell Biology International, 37(1), 87–94.
Saichanma, S., Bunyaratvej, A., & Sila-Asna, M. (2012). In vitro transdifferentiation of corneal epithelial-like cells from human skin-derived precursor cells. International Journal of Ophtalomogy, 5(2), 158–163.
Harkin, D. G., et al. (2015). Concise reviews: can mesenchymal stromal cells differentiate into corneal cells? A systematic review of published data. Stem Cells, 33, 785–791.
Wan, P.-X., Wang, B.-W., & Wang, Z.-C. (2015). Importance of the stem cell microenvironment for ophthalmological cell-based therapy. World Journal Stem Cells, 7(2), 448–460.
Dai, Y., et al. (2014). Non-genetic direct reprogramming and biomimetic platforms in a preliminary study for adipose-derived stem cells into corneal endothelia-like cells. PloS One, 9, e109856.
Théry C (2011) Exosomes: secreted vesicles and intercellular communications. F1000 Biology Reports, 3, 15
Colombo, M., Raposo, G., & Théry, C. (2014). Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annual Review of Cell and Developmental Biology, 30, 255–289.
Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007). Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nature Cell Biology, 9(6), 654–659.
Nazarenko, I., Rana, S., Baumann, A., McAlear, J., Hellwig, A., Trendelenburg, M., et al. (2010). Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation. Cancer Research, 70(4), 1668–1678.
Lai, R. C., Chen, T. S., & Lim, S. K. (2011). Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease. Regenerative Medicine, 6(4), 481–492.
Khan, M., Nickoloff, E., Abramova, T., Johnson, J., Verma, S. K., Krishnamurthy, P., et al. (2015). Embryonic stem cell-derived exosomes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction. Circulation Research, 117, 52–64.
Zhang, J., Guan, J., Niu, X., Hu, G., Guo, S., Li, Q., et al. (2015). Exosomes released from human induced pluripotent stem cells-derived MSCs facilitate cutaneous wound healing by promoting collagen synthesis and angiogenesis. Journal of Translational Medicine, 13, 49.
Nakamura, Y., Miyaki, S., Ishitobi, H., Matsuyama, S., Nakasa, T., Kamei, N., et al. (2015). Mesenchymal-stem-cell-derived exosomes accelerate skeletal muscle regeneration. FEBS Letter, 589(11), 1257–1265.
Yu, B., Zhang, X., & Li, X. (2014). Exosomes derived from mesenchymal stem cells. International Journal of Molecular Science, 15(3), 4142–4157.
Aliotta, J. M., et al. (2007). Alteration of marrow cell gene expression, protein production, and engraftment into lung by lung-derived microvesicles: a novel mechanism for phenotype modulation. Stem Cells, 25, 2245–2256.
Jang, Y.-Y., Collector, M. I., Baylin, S. B., Diehl, A. M., & Sharkis, S. J. (2004). Hematopoietic stem cells convert into liver cells within days without fusion. Nature Cell Biology, 6, 532–539.
Suntres, Z. E. (2013). Therapeutic uses of exosomes. Exosomes Microvescicles, 1, 1–8.
Streilein, J. W. (2003). Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation. Journal of Leukocyte Biology, 74(2), 179–185.
Acknowledgments
The authors acknowledge support from French National Agency for Research (ANR 11 EMMA 023 and ANR-13-PRTS-0001-02) to DA.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of Interest
The authors declare no potential conflict of interest.
Rights and permissions
About this article
Cite this article
Erbani, J., Aberdam, D., Larghero, J. et al. Pluripotent Stem Cells and Other Innovative Strategies for the Treatment of Ocular Surface Diseases. Stem Cell Rev and Rep 12, 171–178 (2016). https://doi.org/10.1007/s12015-016-9643-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12015-016-9643-y